ArticleBlood2016
Anakinra as efficacious therapy for 2 cases of intracranial Erdheim-Chester disease.
Article in Blood, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 25 citations in OpenAlex.
- Literature review of pediatric Erdheim-Chester disease (ECD) and mixed histiocytosis (Langerhans cell histiocytosis/ECD).Annals of translational medicine · 2026Review
- Clinical spectrum of pediatric-onset Erdheim-Chester disease: insights from a single-center case series.Frontiers in pediatrics · 2026Article
- Vertebral involvement in Erdheim-Chester disease: a case report of non-BRAF-driven diagnosis and treatment challenges.Frontiers in oncology · 2026Article
- Successful treatment of non-Langerhans cell histiocytosis with the MEK inhibitor trametinib: a multicenter analysis.Blood advances · 2023Article
- Erdheim-Chester disease: First pediatric case report in ColombiaBiomedica : revista del Instituto Nacional de Salud · 2021Article
- BRAF V600E mutation in Juvenile Xanthogranuloma family neoplasms of the central nervous system (CNS-JXG): a revised diagnostic algorithm to include pediatric Erdheim-Chester disease.Acta neuropathologica communications · 2019Article
- Molecular Profiling of Tumor Tissue and Plasma Cell-Free DNA from Patients with Non-Langerhans Cell Histiocytosis.Molecular cancer therapeutics · 2019Article
- The histopathology of Erdheim-Chester disease: a comprehensive review of a molecularly characterized cohort.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2018Review
- Anakinra Therapy for Non-cancer Inflammatory Diseases.Frontiers in pharmacology · 2018Review
- Treating Heart Inflammation With Interleukin-1 Blockade in a Case of Erdheim-Chester Disease.Frontiers in immunology · 2018Article
- Superior efficacy and similar safety of double dose anakinra in Erdheim-Chester disease after single dose treatment.OncoimmunologyArticle
Corrections and comments
- Comment on
Authors and funding
9 authors at 3 institutions in 1 country.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.